[Voiding difficulties in a child attributed to the use of ipratropium and salbutamol]

Area of Science:

• Pediatric Urology
• Pharmacology
• Respiratory Medicine

Background:

• Urinary voiding difficulties, including urinary hesitancy and variable residual volumes, can significantly impact a child's quality of life.
• Asthma is a common chronic respiratory condition in children, frequently managed with inhaled bronchodilators and corticosteroids.

Observation:

• A 5-year-old female child with asthma presented with new-onset voiding difficulties after regular use of ipratropium and salbutamol inhalers.
• The patient experienced resolution of urinary symptoms upon cessation of the asthma medications.
• Re-challenge with ipratropium and salbutamol confirmed the exacerbation of voiding problems, while inhaled corticosteroids effectively managed her asthma.

Findings:

• Ipratropium and salbutamol, commonly used for asthma, were identified as potential causative agents for functional voiding difficulties in a pediatric patient.
• This adverse effect of ipratropium and salbutamol on bladder function in children has not been previously well-documented in medical literature, although some cases have been reported to pharmacovigilance centers.

Implications:

• Clinicians should consider asthma medications as a potential cause of voiding dysfunction in children, prompting a thorough medication history.
• Understanding the potential interaction between inhaled medications and the autonomic control of the bladder and pelvic floor muscles is crucial for managing pediatric voiding problems.
• This case underscores the importance of vigilant pharmacovigilance for identifying and reporting rare adverse drug effects in pediatric populations.